000			02174 a2200625 4500
005			20250517063340.0
264		0	_c20161107
008			201611s 0 0 eng d
022			_a1949-2553
024	7		_a10.18632/oncotarget.6313 _2doi
040			_aNLM _beng _cNLM
100	1		_aHung, Man-Hsin
245	0	0	_aSET antagonist enhances the chemosensitivity of non-small cell lung cancer cells by reactivating protein phosphatase 2A. _h[electronic resource]
260			_bOncotarget _cJan 2016
300			_a638-55 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAged
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aBlotting, Western
650	0	4	_aCarcinoma, Non-Small-Cell Lung _xdrug therapy
650	0	4	_aCell Line, Tumor
650	0	4	_aDNA-Binding Proteins
650	0	4	_aDisease-Free Survival
650	0	4	_aDrug Synergism
650	0	4	_aEnzyme Activation _xdrug effects
650	0	4	_aFemale
650	0	4	_aHistone Chaperones _xantagonists & inhibitors
650	0	4	_aHumans
650	0	4	_aImmunohistochemistry
650	0	4	_aLung Neoplasms _xdrug therapy
650	0	4	_aMale
650	0	4	_aMice, Nude
650	0	4	_aMiddle Aged
650	0	4	_aPaclitaxel _xadministration & dosage
650	0	4	_aProtein Phosphatase 2 _xmetabolism
650	0	4	_aProto-Oncogene Proteins c-akt _xmetabolism
650	0	4	_aQuinazolines _xadministration & dosage
650	0	4	_aRNA Interference
650	0	4	_aReverse Transcriptase Polymerase Chain Reaction
650	0	4	_aTranscription Factors _xantagonists & inhibitors
650	0	4	_aXenograft Model Antitumor Assays
700	1		_aWang, Cheng-Yi
700	1		_aChen, Yen-Lin
700	1		_aChu, Pei-Yi
700	1		_aHsiao, Yung-Jen
700	1		_aTai, Wei-Tien
700	1		_aChao, Ting-Ting
700	1		_aYu, Hui-Chuan
700	1		_aShiau, Chung-Wai
700	1		_aChen, Kuen-Feng
773	0		_tOncotarget _gvol. 7 _gno. 1 _gp. 638-55
856	4	0	_uhttps://doi.org/10.18632/oncotarget.6313 _zAvailable from publisher's website
999			_c25454533 _d25454533